In medical device comparison studies, equivalency test is commonly used to demonstrate two measurement methods agree up to a pre-specified performance goal based on the paired repeated measures. Such equivalency test often involves controlling the absolute differences that depend on both the mean and variance parameters, and poses some challenges for statistical analysis. For example, for the oximetry comparison study that motivates our research, FDA has clear guidelines approving an investigational pulse oximeter in comparison to a standard oximeter via testing the root mean squares (RMS), a composite measure of both mean and variance parameters. For the hypothesis testing of this composite measure, existing methods have been either exploratory or relying on the large-sample normal approximation with conservative and unsatisfactory performance. We develop a novel generalized pivotal test to rigorously and accurately test the system equivalency based on RMS. The proposed method has well-controlled type I error and favorable performance in our extensive numerical studies. When analyzing data from an oximetry comparison study, aiming to demonstrate performance equivalency between an FDA-cleared oximetry system and an investigational system, our proposed method resulted in a highly significant test result strongly supporting the system equivalency. We also provide efficient R programs for the proposed method in a publicly available R package. Considering that many practical equivalency studies of diagnostic devices are * Email: baolin@umn.edu 1 of small to medium sizes, our proposed method and software timely bridge an existing gap in the field.
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Introduction
In medical device comparison studies, equivalency test is commonly used to demonstrate two measurement methods agree up to a pre-specified performance goal based on the paired repeated measures. For example, for the oximetry comparison study that motivates our research, FDA has clear guidelines on how to establish the acceptance of a new investigational oximeter in comparison to a standard oximeter through data collection and a formal hypothesis testing framework based on testing the root mean squares (RMS), which is a composite measure of both mean and variance parameters. However existing methods are mostly exploratory (Lin, 1989 (Lin, , 1992 Altman, 1999, 2007) or have relied on the large-sample normal approximation with conservative and unsatisfactory performance (Pennello, 2002 (Pennello, , 2003 Ndikintum and Rao, 2016) .
In this paper, we develop statistical methods for the equivalency test problem in the diagnostic device comparisons. We offer novel insights to the statistical problems with respect to the equivalency test and provide accurate and efficient solutions for practical use. Specifically we develop powerful statistical methods with robust statistical properties. The newly developed methods are motivated by the novel generalized pivotal statistics based approach (Weerahandi, 1995) . Through extensive numerical studies, we demonstrate favorable performance of the proposed methods: they achieve higher power than the existing methods by a large margin, and can produce accurate confidence intervals to precisely quantify the variation of key parameter of interest. We further develop a publicly available R package that implements the new methods. Our proposed statistical methods along with the R package provide useful practical tools to the general community and timely bridge the gap in the field.
The rest of the paper proceeds as follows. Section 2 explains the root mean squares (RMS) testing problem in a linear random-effects model and our proposed method based on a generalized inference approach. Next, we study the performance of our method through simulation studies in Section 3 and apply the new method to the pulse oximetry data in Section 4. A discussion is given in Section 5.
Throughout the paper, we will mainly focus on intuitive ideas and delegate all technical details to the Appendix.
Statistical methods
Consider a random-effects ANOVA model, Y i j = µ + u i + ε i j , i = 1, · · · , n; j = 1, · · · , m i , where µ is the overall mean, the random effects term u i ∼ N(0, σ 2 b ) and the random error components ε i j ∼ N(0, σ 2 w )
are all independent. For paired repeated measure data, Y i j will describe the differences of two measures (e.g. pulse oximeter measurement and the co-oximeter measurement). Denote
and
Here σ 2 b is the between-level variance, σ 2 w is the within-level variance, and µ quantifies the average mean value. This is a special case of the linear mixed effects model (LMM; Laird and Ware, 1982) .
In the following, we use capital letters to denote the random variables, e.g.
, and the corresponding small letters to denote the observed data, e.g. (y i j , y i , y).
Our main interest is the root mean squares (RMS) parameter defined as ρ = µ 2 + σ 2 b + σ 2 w . In the paired repeated measure comparison, ρ quantifies the average absolute difference between the two measures, since E(Y 2 i j ) = ρ 2 . It is of interest to test H 0 : ρ ≥ ρ 0 versus H a : ρ < ρ 0 , where ρ 0 is a pre-specified acceptable threshold. In addition, we want to compute a confidence interval (CI) for ρ to quantify its variation.
Per the FDA guideline, a pulse oximeter is approvable if the null hypothesis H 0 : ρ ≥ ρ 0 can be rejected in favor of the alternative hypothesis H a : ρ < ρ 0 with a pre-specified value ρ 0 . For example ρ 0 = 3% is often used for transmittance, wrap and clip pulse sensors.
The RMS parameter ρ involves both the mean parameter µ and variance parameters (σ 2 b , σ 2 w ). It poses significant challenges to construct exact methods for inference. To our knowledge, this has not been well-studied in the filed. Partly owing to the composite nature of ρ and the presence of nuisance parameters, the large-sample based normal approximation generally does not perform well (Pennello, 2002 (Pennello, , 2003 Ndikintum and Rao, 2016) . We note that the statistical inference of individual mean and variance parameters has been well-studied, and a variety of methods exist (Ting et al., 1990; Zhou and Mathew, 1994; Park and Burdick, 2003; Lee et al., 2004; Park and Burdick, 2004; Iyer et al., 2004; Burdick et al., 2006) . In the following we adopt the method of generalized inference (Tsui and Weerahandi, 1989; Weerahandi, 1993) to conduct significance test and calculate CI for ρ.
Generalized test statistic
In the presence of nuisance parameters, the key idea of generalized inference is to construct a generalized pivotal quantity/test statistic, which is defined as a function of observed data, parameters and random variables. It has a known distribution free of any unknown parameters, and hence can be used to conduct hypothesis test and calculate CI for the parameter of interest. Compared to the traditional statistical inference based on the pivotal statistic, which is defined as the function of parameters and random variables with a known distribution, the generalized inference allows the incorporation of observed data.
We refer the reader to the monograph of Weerahandi (1995) for a detailed discussion along with relevant examples.
Denote the summary statistics,
essentially the sample means and variances, and hence they are independent random variables.
Let sse denote the value of SSE based on the observed data. Define
Note that given the observed data, Q w follows a scaled inverse chi-square distribution, and furthermore, Q w equals to σ 2 w at the observed data, i.e. when SSE takes value sse.
. TreatingȲ i as the outcomes regressed onto a constant with weight W i , and based on the standard linear regression theory, we can check that
is a χ 2 n−1 random variable. FurthermoreȲ and SSR are independent. Based on equation (2), we can solve σ 2 b as a deterministic function of (Ȳ , σ 2 w , SSR), denoted as h(Ȳ , σ 2 w , SSR).
whereȳ = (ȳ 1 , · · · ,ȳ n ) denote the observed sample means. Given the observed data, both the distributions of Q w and SSR are known, hence Q b has a distribution free of any parameters, and Q b equals to σ 2 b at the observed data. Iyer et al., 2004) . Define the following generalized test statistic
Given the observed data, Q µ has a known distribution free of any parameters. Furthermore, at the observed data, Q b and Q w reduce to σ 2 b and σ 2 w , and hence Q µ equals µ 2 .
Generalized test p-value and generalized CI calculation
For inference on the RMS parameter ρ, we consider the following generalized test statistic,
We treat those observed quantities, e.g. (ȳ, sse), as constants, and the distribution of Q is induced by (SSE, SSR, Z). We note that the generalized test statistic Q and its distribution require only the summary statistics: sse andȳ. It is clear that the distribution of Q does not depend on any unknown parameters given the observed data. We also note that for the observed data, Q reduces to ρ 2 = σ 2 w + σ 2 b + µ 2 .
The generalized p-value for testing H 0 : ρ ≥ ρ 0 can be computed as Pr(Q ≥ ρ 2 0 ), and a 100(1 − α)% generalized CI for ρ can be computed as [ Q (α/2) , Q (1−α/2) ], where Q (α) denotes the α-th percentile of the distribution of Q (Tsui and Weerahandi, 1989; Weerahandi, 1993) .
Following the generalized test literature, the statistical inference can be made based on generating random numbers from the distribution of Q as follows:
(i) simulate (SSE/σ 2 w ) from the χ 2 N−n distribution to generate Q w ;
(ii) simulate SSR from the χ 2 n−1 distribution, and compute Q b from Q w and SSR;
(iii) simulate Z from N(0, 1) distribution, and compute Q µ from Q w , Q b and Z;
Given the simulated random realizations, denoted as (Q 1 , · · · , Q B ), we compute the generalized test p-value for testing H 0 :
and compute the generalized CI for ρ with 1 − α coefficient as
where Q (k) denotes the ordered Q-values.
Numerical computation
Note that conditional on the Q w and Q b , Q µ follows a normal distribution with meanỹ and variance
where S χ 2 1 (·|λ ) denotes the tail probability of a χ 2 1 distribution with non-centrality parameter λ . Therefore we can compute the generalized test p-value as
The corresponding generalized CI can be computed by reversely solving the critical values of Q at the generalized p-values of α/2 and (1 − α/2). We note that this practice amounts to analytically integrating out the random variable Z from the marginal distribution of Q, which avoids the need for actual Monte
Carlo simulation of Z and can lead to more accurate test p-value and CI calculation.
Large-sample normal approximation
The existing large-sample test methods are based on the normal approximation of R = ∑ i, j Y 2 i j /N with mean and variance (Pennello, 2002 (Pennello, , 2003 Ndikintum and Rao, 2016 )
The parameter estimates can be readily obtained from fitting a LMM to the data. The existing methods differ in their calculation of the variance, leading to a score test and Wald test, denoted as Z-score and Z-Wald respectively, depending on whether the variance is computed under the null hypothesis or not.
In the next section we conduct simulation studies to investigate the performance of proposed method (with B = 10 4 , denoted as GT) compared to the existing large-sample test methods.
Numerical studies
In the numerical studies, we have found that the Z-Wald test has very liberal type I errors (the complete results are available at the Supporting Information Section S1). Hence we only include the Z-score test in the following comparison.
We conducted two sets of simulations. First, we simulate an unbalanced study with parameters,
, estimated from a pulse oximetry comparison study (see Section 4).
We consider n = 16 subjects with m i ranging from 5 to 20, and n = 20 subjects with m i ranging from 5 to 24. We set ρ 0 = 2.1 under the null hypothesis and ρ 0 = 3 for estimating power. Secondly, we consider a balanced study with combinations of n = (10, 20, 30), m = (5, 10, 20
, and setting µ = ρ 2 − σ 2 w − σ 2 b . We test H 0 : ρ ≥ 3, and set ρ = 3 under the null hypothesis and ρ = √ 6 for estimating power.
Type I errors
We conduct 10 4 null simulations to evaluate the type I errors at the significance level α = 0.01 and 0.05. Overall we have obtained very similar patterns across all simulation scenarios. Here we present the results for the unbalanced study and the balanced study with n = 20, m = 10. The complete simulation results can be found in the Supporting Information Section S1. Table 1 summarizes the empirical type I errors for the unbalanced study with n = 16, 20 subjects. Table 2 shows the empirical type I errors for balanced study with
The proposed test (denoted as GT) is compared to the Z-score test. Overall the results show that the type I errors are well controlled for the proposed method, while the Z-score test is more conservative especially at more stringent significance level. For the proposed GT, generally larger µ (smaller σ 2 w + σ 2 b ) leads to more accurate control of type I errors. Table 2 : Empirical type I errors at significance level α estimated over 10 4 null simulations. Data are simulated from n = 20 subjects each with m = 10 measures and ρ = 3. GT is the proposed test, Z-score is the score based Z-test. 
Power
For the unbalanced study, we consider testing H 0 : ρ > 3. For the balanced study, we set ρ 0 = √ 6 and consider testing H 0 : ρ > 3. We use 10 4 Monte Carlo simulations to estimate power under each configuration. Overall, we have observed very similar conclusions across simulation scenarios. Here we report the results for the unbalanced study and balanced study with n = 20, m = 10. The complete results are available at the Supporting Information Section S1. Table S6 summarizes the power for the unbalanced study. Table 4 summarizes the power for (σ 2 w + σ 2 b )/6 = (0.2, 0.8) and σ 2 w /σ 2 b = (1/3, 3) under the 0.01 and 0.05 significance levels. Overall the proposed method performs remarkably better than the Z-score test by a large margin, especially at more stringent significance level. For the proposed GT, (1) smaller between-subject variance σ 2 b leads to higher power; and (2) larger µ (smaller σ 2 w + σ 2 b ) also leads to higher power. Table 4 : Power (%) at significance level α estimated over 10 4 simulations. Data are simulated for n = 20 subjects each with m = 10 measures under σ 2 w + σ 2 b + µ 2 = 6. We are testing H 0 : ρ ≥ 3. GT is the proposed test, and Z-score is the score based Z-test. 3.3 CI calculation Table 5 and S9 summarize the coverage probability (CP) and average width (AW) of computed 90% CIs over 10 4 simulations. Overall we can see that the CIs produced by the proposed method (denoted as GCI) have very good coverage probability close to the nominal 90% level. As expected, the Z-score test based approach has more conservative performance, with CP generally much larger than the desired 90% level and CI much wider than the GCI. Table 5 : Coverage probability (CP) and average width (AW) of 90% CI for ρ estimated over 10 4 simulations. GCI is the proposed test, Z-score is the score based Z-test. Data are simulated from an unbalanced study with n subjects and ρ = 2.1. Table 6 : Coverage probability (CP) and average width (AW) of 90% CI estimated over 10 4 simulations. Data are simulated from a balanced study with n = 20 subjects each with m = 10 measures and ρ = 3. GCI is the proposed test, Z-score is the score based Z-test. 
Application to oximetry comparison study
For illustration, we consider an oximetry comparison study conducted by a medical device company to demonstrate equivalency in performance between an FDA-cleared oximetry system and an investigational oximeter. The study has obtained multiple measures of difference of tissue oxygen saturation levels for a cohort of healthy, non-smoking adults and adolescent volunteers. We model the measured oxygen differences with a linear mixed-effects model (LMM), and investigate the system equivalency based on testing H 0 : ρ ≥ 3%.
For illustrative purposes, we analyze a representative dataset from 16 individuals and provide the summary data. Table 7 listed the sample size m i and meanȳ i for each individual. The observed sse = 221.037% 2 . We note that the LMM estimation requires only (ȳ, sse) without the need of individual level data, similar to the proposed generalized test method (see Appendix for details). and a much narrower CI, offering stronger support for the system equivalency.
Discussion
We have proposed a generalized significance test method with accurate CI calculation for the root mean squares parameter (RMS) in a linear mixed-effects model. The RMS parameter directly quantifies the total absolute variation of outcomes and can be used to test equivalency in paired medical device comparison studies. Compared to the existing large-sample test methods, our proposed method shows more powerful performance and produces CIs with more accurate coverage probabilities. When applied to a pulse oximetry equivalency study, our proposed method yielded more signifiant test p-value and stronger evidence to support the system equivalency, as compared to the existing methods. We have also conducted extensive numerical studies to illustrate the very favorable performance of our proposed method.
The new approach has been implemented in a publicly available R package. The new method along with the R package provide useful and practical tools, and timely bridge an existing gap in the field.
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Supporting information
An R package implementing the new method is available at http://github.com/baolinwu/RAMgt.
Supporting information contains complete simulation results (Section S1) and sample scripts to install and use the developed R package (Section S2).
Lee, Y., Shao, J., and Chow, S. A Sufficient statistics, likelihood calculation, and parameter estimation . We can analytically compute its inverse and determinant, and check that
2 (up to some constant that does not depend on data). The log likelihood can then be shown proportional to
where sse = ∑ i y i −ȳ i 2 . Therefore, we just need (ȳ, sse) to compute likelihood to estimate parameters, the same as the proposed generalized test method, as shown previously.
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S1 Simulation study
We conducted two sets of simulations. First, we simulate an unbalanced study with parameters, (µ = −0.57, σ w = 1.48, σ b = 1.38), estimated from a pulse oximetry comparison study (see main text Section 4). We consider n = 16 subjects with m i ranging from 5 to 20, and n = 20 subjects with m i ranging from 5 to 24. We set ρ 0 = 2.1 under the null hypothesis and ρ 0 = 3 for estimating power. Secondly, we consider a balanced study with combinations of n = (10, 20, 30), m = (5, 10, 20
, and setting µ = ρ 2 − σ 2 w − σ 2 b . We test H 0 : ρ ≥ 3, and set ρ = 3 under the null hypothesis and ρ = √ 6 for estimating power. The proposed test (denoted as GT) is compared to the Z-score/Z-Wald tests.
The main text contains the simulation results for the unbalanced studies. Here we summarize the complete simulation results for the balanced studies.
S1.1 Type I errors
We conduct 10 4 null simulations to evaluate the type I errors at the significance level α = 0.01 and 0.05.
Tables S1-S3 summarize the type I errors for the balanced studies. Overall we have obtained very similar patterns across all simulation scenarios. The type I errors are well controlled for the proposed method.
The Z-score test is more conservative especially at more stringent significance level, and the Z-Wald test has severely inflated type I errors. The Z-score test has largely improved performance with increasing sample sizes. In contrast, the GT has relatively stable performance across all scenarios. Overall, larger µ (smaller σ 2 w + σ 2 b ) leads to more accurate control of type I errors for the proposed GT. Table S1 : Empirical type I errors at significance level α estimated over 10 4 null simulations. Data are simulated from n = 10 subjects each with m measures and ρ = 3. GT is the proposed test, Z-score is the score based Z-test. Table S2 : Empirical type I errors at significance level α estimated over 10 4 null simulations. Data are simulated from n = 20 subjects each with m measures and ρ = 3. GT is the proposed test, Z-score is the score based Z-test. Table S3 : Empirical type I errors at significance level α estimated over 10 4 null simulations. Data are simulated from n = 30 subjects each with m measures and ρ = 3. GT is the proposed test, Z-score is the score based Z-test. 
S1.2 Power
For the unbalanced study, we consider testing H 0 : ρ > 3. For the balanced study, we set ρ 0 = √ 6 and consider testing H 0 : ρ > 3. We use 10 4 Monte Carlo simulations to estimate power under each configuration. Tables S4-S6 summarize the power. Overall, we have observed very similar conclusions across simulation scenarios. The proposed GT performs better than the Z-score test by a large margin.
For the proposed GT, (1) smaller between-subject variance σ 2 b leads to larger power; and (2) larger µ (smaller σ 2 w + σ 2 b ) also leads to larger power. Table S4 : Power (%) at significance level α estimated over 10 4 simulations. Data are simulated for n = 10 subjects each with m measures under σ 2 w + σ 2 b + µ 2 = 6. We are testing H 0 : ρ ≥ 3. GT is the proposed test, and Z-score is the score based Z-test. Table S5 : Power (%) at significance level α estimated over 10 4 simulations. Data are simulated for n = 20 subjects each with m measures under σ 2 w + σ 2 b + µ 2 = 6. We are testing H 0 : ρ ≥ 3. GT is the proposed test, and Z-score is the score based Z-test. Table S6 : Power (%) at significance level α estimated over 10 4 simulations. Data are simulated for n = 30 subjects each with m measures under σ 2 w + σ 2 b + µ 2 = 6. We are testing H 0 : ρ ≥ 3. GT is the proposed test, and Z-score is the score based Z-test. S1.3 CI calculation Table S7 -S9 summarize the coverage probability (CP) and average width (AW) of computed 90% CIs over 10 4 simulations. Overall we can see that the CIs produced by the proposed method (denoted as GCI) have very good coverage probability close to the nominal 90% level. As expected, the Z-score test based approach has more conservative performance, with CP generally much larger than the desired 90% level and CI much wider than the GCI. Table S7 : Coverage probability (CP) and average width (AW) of 90% CI estimated over 10 4 simulations. Data are simulated from a balanced study with n = 20 subjects each with m = 10 measures and ρ = 3. GCI is the proposed test, Z-score is the score based Z-test. Table S8 : Coverage probability (CP) and average width (AW) of 90% CI estimated over 10 4 simulations. Data are simulated from a balanced study with n = 20 subjects each with m = 10 measures and ρ = 3. GCI is the proposed test, Z-score is the score based Z-test. Table S9 : Coverage probability (CP) and average width (AW) of 90% CI estimated over 10 4 simulations. Data are simulated from a balanced study with n = 30 subjects each with m = 10 measures and ρ = 3. GCI is the proposed test, Z-score is the score based Z-test. 
S2 R package
The following are some sample codes to install and use the 'RAMgt' R package. The oximetry comparison data can be analyzed to reproduce the analysis results reported in the main paper.
## PO comparison study ng = c (9, 10, 10, 10, 5, 10, 10, 10, 10, 10, 10, 10, 2, 10, 10, 10) mus = c (-0.026,0.447,0.083,-0.103,-2.587,-0.61,0.04,-0.593, 0.963,0.643, - 
